Active substance
Bethanechol
- US FDA 55
- Health Canada 2
- US price lines 4
- NHS prices 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DUVOID | 50MG | tablet · oral | CHARTWELL RX | Prescription | 22 Mar 1978 |
| DUVOID | 10MG | tablet · oral | CHARTWELL RX | Prescription | 22 Mar 1978 |
| DUVOID | 25MG | tablet · oral | CHARTWELL RX | Prescription | 22 Mar 1978 |
| BETHANECHOL CHLORIDE | 5MG | tablet · oral | UPSHER SMITH LABS | Prescription | 1 Jun 2005 |
| BETHANECHOL CHLORIDE | 10MG | tablet · oral | UPSHER SMITH LABS | Prescription | 1 Jun 2005 |
| BETHANECHOL CHLORIDE | 25MG | tablet · oral | UPSHER SMITH LABS | Prescription | 1 Jun 2005 |
| BETHANECHOL CHLORIDE | 50MG | tablet · oral | UPSHER SMITH LABS | Prescription | 1 Jun 2005 |
| BETHANECHOL CHLORIDE | 50MG; 5MG; 10MG; 25MG | tablet · oral | CHARTWELL RX | Prescription | 26 Oct 2007 |
| BETHANECHOL CHLORIDE | 5MG; 10MG; 25MG; 50MG | tablet · oral | AMNEAL PHARM | Prescription | 21 Nov 2007 |
| BETHANECHOL CHLORIDE | 5MG; 10MG; 25MG; 50MG | tablet · oral | HERITAGE PHARMA | Prescription | 4 May 2010 |
| URECHOLINE | 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | TEVA BRANDED PHARM | Discontinued | 12 Oct 1948 |
| URECHOLINE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | TEVA BRANDED PHARM | Discontinued | 12 Oct 1948 |
| BETHANECHOL CHLORIDE | 10MG | tablet · oral | WATSON LABS | Discontinued | 11 Nov 1974 |
| BETHANECHOL CHLORIDE | 5MG | tablet · oral | WATSON LABS | Discontinued | 26 Nov 1974 |
| BETHANECHOL CHLORIDE | 25MG | tablet · oral | WATSON LABS | Discontinued | 14 Jan 1975 |
| BETHANECHOL CHLORIDE | 10MG | tablet · oral | LANNETT | Discontinued | 29 Jul 1975 |
| MYOTONACHOL | 5MG; 10MG; 25MG | tablet · oral | GLENWOOD | Discontinued | 24 Sep 1975 |
| BETHANECHOL CHLORIDE | 25MG | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | 16 Dec 1975 |
| BETHANECHOL CHLORIDE | 5MG | tablet · oral | LANNETT | Discontinued | 16 Jun 1976 |
| BETHANECHOL CHLORIDE | 25MG | tablet · oral | LANNETT | Discontinued | 1 Jul 1976 |
| BETHANECHOL CHLORIDE | 25MG | tablet · oral | WATSON LABS | Discontinued | 26 Aug 1977 |
| BETHANECHOL CHLORIDE | 10MG | tablet · oral | WATSON LABS | Discontinued | 26 Aug 1977 |
| BETHANECHOL CHLORIDE | 50MG | tablet · oral | WATSON LABS | Discontinued | 16 Jul 1981 |
| URECHOLINE | 10MG | tablet · oral | ODYSSEY PHARMS | Discontinued | 29 May 1984 |
| URECHOLINE | 25MG | tablet · oral | ODYSSEY PHARMS | Discontinued | 29 May 1984 |
30 more — full table
Canada Canada — marketed products (Health Canada)
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | BETHANECHOL 10 MG TABLET | $0.14989 | per EA | 23 Sep 2026 |
| US NADAC | BETHANECHOL 25 MG TABLET | $0.18782 | per EA | 23 Sep 2026 |
| US NADAC | BETHANECHOL 5 MG TABLET | $0.12208 | per EA | 23 Sep 2026 |
| US NADAC | BETHANECHOL 50 MG TABLET | $0.27036 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Bethanechol chloride 10mg tablets | £18.51 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Bethanechol chloride 25mg tablets | £27.26 | 100 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.